Journal of Kermanshah University of Medical Sciences
Peer-reviewed Medical Quarterly
Outlines
The effect of brief behavioral activation treatment on symptoms of depression, mental health and quality of life among the patients with opioid abuse
Author(s):
1Dept. of Clinical Psychology, Kharazmi University, Tehran, Iran
2Dept. of Psychology, Razi University, Kermanshah, Iran
*Corresponding Author: Corresponding author: Khodamorad Momeni, Dept. of Psychology, Razi University, Kermanshah, Iran, Tel: +98 9181323767 Email: [email protected]
Published online:May 29, 2015
Article type:Research Article
Received:Dec 01, 2014
Accepted:May 12, 2015
How to Cite:Hasani J, Parhoon H, Momeni K. The effect of brief behavioral activation treatment on symptoms of depression, mental health and quality of life among the patients with opioid abuse. J Kermanshah Univ Med Sci. 2015;19(2):e70706. doi: https://doi.org/10.22110/jkums.v19i2.2209
Abstract
Background: Depression is one of the most common mental disorders comorbid with with substance use disorder. This research was aimed to evaluate the effect of brief behavioral activation treatment on the symptoms of depression, mental health and quality of life among the patients with opioid use disorders.
Methods: In a quasi-experimental study with pretest-posttest control group design, 24 patients taking opiates were selected through convenience sampling method and randomly assigned into experimental and control groups. The experimental group was treated for two months. BDI-II, GHQ-28, WHOQOL-BREF were given to both groups before and after treatment and in the 2-month followup period. The results were analyzed using mixed analysis of variance.
Results: The results showed that brief behavioral activation treatment significantly reduced the symptoms of depression (P<0.01) and increased mental health (p<0.01) in the experimental group in the post-test and follow-up phases, but had no significant impact on the patients’ quality of life (P>0.05).
Conclusion: brief behavioral activation treatment is capable of reducing the severity of symptoms of depression and improving the mental health of patients with substance use disorders.
References
- 1.The references of this article is available on PDF.
Copyright
© 2015, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
5
Nov
2025
The Effect of Behavioral Activation Treatment on Symptoms of Depression, Anxiety, and General Health in Individuals with Depression
Sahar Amiri,
Fatemeh Khosravi Saleh Baberi,
Soheila Babakhanzadeh,
Masoumeh Jalili
Amiri S, Khosravi Saleh Baberi F, Babakhanzadeh S, Jalili M. The Effect of Behavioral Activation Treatment on Symptoms of Depression, Anxiety, and General Health in Individuals with Depression. J Arch Mil Med. 2025;13(4):e164862. doi: https://doi.org/10.5812/jamm-164862
22
May
2018
Buprenorphine Added on Brief Cognitive Behavioral Therapy for Treatment of Methamphetamine Use Disorder
Schwann Shariatirad,
Alireza Mahjoub,
Ashraf Haqiqi,
Mohsen Rezaei Hemami,
Babak Tofighi,
Hamed Ekhtiari
,et al.Shariatirad S, Mahjoub A, Haqiqi A, Rezaei Hemami M, Tofighi B, et al. Buprenorphine Added on Brief Cognitive Behavioral Therapy for Treatment of Methamphetamine Use Disorder. Iran J Psychiatry Behav Sci. 2018;12(2):e11529. doi: https://doi.org/10.5812/ijpbs.11529
28
Nov
2022
The Effectiveness of Group Dialectical Behavior Therapy and Structured Matrix Treatment on Quit Addiction Self-efficacy, Distress Tolerance, and Mindfulness in Individuals with Stimulant Drug Abuse
Sakineh Basereh,
Sahar Safarzadeh,
Farzaneh Hooman
Basereh S, Safarzadeh S, Hooman F. The Effectiveness of Group Dialectical Behavior Therapy and Structured Matrix Treatment on Quit Addiction Self-efficacy, Distress Tolerance, and Mindfulness in Individuals with Stimulant Drug Abuse. J Health Rep Technol. 2022;8(4):e127427. doi: https://doi.org/10.5812/jhrt-127427
20
Mar
2015
Effectiveness of Acceptance-Commitment Therapy on Anxiety and Depression among Patients on Methadone Treatment: A Pilot Study
Amir Rezaei Ardani,
Mozhgan Saedy,
Shirin Kooshki,
Mahmoud Jamali Firouzabadi,
Susan Emamipour
Rezaei Ardani A, Saedy M, Kooshki S, Jamali Firouzabadi M, Emamipour S. Effectiveness of Acceptance-Commitment Therapy on Anxiety and Depression among Patients on Methadone Treatment: A Pilot Study. Iran J Psychiatry Behav Sci. 2015;9(1):-. doi: https://doi.org/10.17795/ijpbs222
3
Dec
2018
Inpatient Buprenorphine-Assisted Withdrawal for Treatment of Vulnerable Adolescents with Opioids Use Disorder in Zahedan, Iran: An Observational Study
Mahboubeh Firouzkouhi Moghadam,
Seyed Sepehr Hashemian,
Ahmad Hajebi,
Masoud Pishjoo,
Alireza Noroozi
Firouzkouhi Moghadam M, Hashemian SS, Hajebi A, Pishjoo M, Noroozi A. Inpatient Buprenorphine-Assisted Withdrawal for Treatment of Vulnerable Adolescents with Opioids Use Disorder in Zahedan, Iran: An Observational Study. Int J High Risk Behav Addict. 2019;8(1):e66470. doi: https://doi.org/10.5812/ijhrba.66470
Download PDF289.64 KB
Crossmark
Checking
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles